Regis CORP Form 4 insider transactions

Michelle St. Lawrence DeVore, SVP of Marketing at Regis Corp, was granted 2,500 shares of common stock on November 22, 2024, as part of a vesting schedule.

Director Mark Light acquired 3,200 shares of Regis Corp stock through a stock award, increasing his holdings to 8,226 shares after adjusting for a reverse stock split.

Director Lockie Andrews of Regis Corp acquired 3,200 shares of common stock through a stock award, as reported in a recent SEC filing.

A Regis Corp director, Michael Joseph Mansbach, acquired 3,200 shares of common stock through a stock award.

Director Michael Merriman acquired 4,800 shares of Regis Corp stock through a stock award, as reported in a recent SEC filing.

Director Nancy Cunningham Benacci acquired 3,200 shares of Regis Corp stock through a stock award that vests in the future.

A Regis Corp director, M Ann Rhoades, acquired 3,200 shares of common stock as part of a stock award.

Regis Corp's CEO, Matthew Doctor, amended a previous filing to correct the number of shares withheld for taxes and to adjust for a reverse stock split.

Regis Corp's Chief Financial Officer, Kersten Delores Zupfer, filed an amended SEC Form 4 to correct an underreporting of shares withheld in a previous transaction.

Kersten Delores Zupfer, Chief Financial Officer of Regis Corp, reported the disposal of 759 shares of common stock on November 5, 2024.

EVP Brand Operations at Regis Corp, Michael Heath Ferranti, disposed of 93 shares of common stock on November 5, 2024, to cover tax obligations.

EVP James Raymon Suarez of Regis Corp reports disposing of 176 shares to cover tax obligations following a reverse stock split and PSU cancellation.

Regis Corp CEO Matthew Doctor disposed of 339 shares of common stock on November 5, 2024, to cover tax obligations, reducing his holdings to 3,292 shares.

Kersten Delores Zupfer, CFO of Regis Corp, reported the disposal of 27 common stock shares to cover tax obligations following a 1-for-20 reverse stock split.